Nuvalent, Inc.
NUVL
50 insider filings · Latest: Jul 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Jul 10 8:30 PM | Henry E. PelishChief Scientific Officer | Sale | 2,111 | $123.81 | $261.4K | 63,493(D) | View → |
| Jul 9, 2026 | Jul 9 8:30 PM | Henry E. Pelish | Proposed Sale | 2,111 | $123.81 | $261.4K | — | View → |
| Jul 6, 2026 | Jul 8 8:30 PM | James Richard PorterDirector, President and CEO | Sale | 30,000 | $123.72 | $3.7M | 324,879(D) | View → |
| Jul 1, 2026 | Jul 6 8:31 PM | Darlene NociChief Development Officer | Sale | 23,000 | $123.59 | $2.8M | 58,117(D) | View → |
| Jul 1, 2026 | Jul 6 8:30 PM | Alexandra BalcomChief Financial Officer | Sale | 11,430 | $123.58 | $1.4M | 85,533(D) | View → |
| Jul 1, 2026 | Jul 1 8:31 PM | Alexandra Balcom | Proposed Sale | 22,860 | $123.53 | $2.8M | — | View → |
| Jun 29, 2026 | Jul 1 8:30 PM | Darlene NociChief Development Officer | Sale | 5,500 | $123.51 | $679.3K | 58,117(D) | View → |
| Jun 9, 2026 | Jun 11 8:30 PM | Darlene NociChief Development Officer | Sale | 20,000 | $122.81 | $2.5M | 58,117(D) | View → |
| Jun 8, 2026 | Jun 10 8:30 PM | James Richard PorterDirector, President and CEO | Sale | 30,000 | $88.53 | $2.7M | 324,879(D) | View → |
| Jun 9, 2026 | Jun 9 8:04 PM | Darlene Noci | Proposed Sale | 48,500 | $122.81 | $6.0M | — | View → |
| Jun 8, 2026 | Jun 8 8:03 PM | James Richard Porter | Proposed Sale | 90,000 | $90.48 | $8.1M | — | View → |
| Jun 1, 2026 | Jun 3 8:30 PM | Alexandra BalcomChief Financial Officer | Sale | 11,430 | $98.69 | $1.1M | 85,533(D) | View → |
| May 28, 2026 | Jun 1 8:31 PM | Darlene NociChief Development Officer | Sale | 5,500 | $107.80 | $592.9K | 58,117(D) | View → |
| May 28, 2026 | Jun 1 8:30 PM | Deborah Ann MillerChief Legal Officer | Sale | 5,500 | $107.84 | $593.1K | 59,634(D) | View → |
| May 4, 2026 | May 6 8:30 PM | James Richard PorterDirector, President and CEO | Sale | 30,000 | $101.69 | $3.1M | 324,879(D) | View → |
| May 1, 2026 | May 5 8:30 PM | Alexandra BalcomChief Financial Officer | Sale | 11,430 | $99.00 | $1.1M | 85,533(D) | View → |
| Apr 30, 2026 | May 1 8:30 PM | Deborah Ann MillerChief Legal Officer | Sale | 5,500 | $99.22 | $545.7K | 59,634(D) | View → |
| Apr 29, 2026 | May 1 8:30 PM | Darlene NociChief Development Officer | Sale | 5,500 | $99.55 | $547.5K | 58,117(D) | View → |
| Apr 30, 2026 | Apr 30 8:24 PM | DEBORAH MILLER | Proposed Sale | 16,500 | $99.10 | $1.6M | — | View → |
| Apr 9, 2026 | Apr 13 8:30 PM | Henry E. PelishChief Scientific Officer | Sale | 3,093 | $104.48 | $323.2K | 65,604(D) | View → |
Page 1 of 5
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Jan 23 9:31 PM | Deborah Ann MillerChief Legal Officer | Option Exercise | 14,300 | $27.85 | 75,154(D) | View → |
| Jan 21, 2026 | Jan 23 9:31 PM | Deborah Ann MillerChief Legal Officer | Option Exercise | 700 | $27.85 | 89,454(D) | View → |
← Previous
Page 3 of 3